InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Einhorn Andrew J., Chief Financial Officer. Insider active across 3 companies, notably Osmotica Pharmaceuticals plc. In total, 4 reports have been logged. Activity tracked since 18 May 2021. The latest transaction was filed on 24 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
9,607 shares@ US$1.13100.0% of flowOrdinary SharesSEC:0001104659-22-007844
9,607 shares@ US$1.1350.0% of flowOrdinary SharesSEC:0001104659-22-007844:0
6,467 shares@ US$3.12100.0% of flowOrdinary SharesSEC:0001104659-21-069879
6,467 shares@ US$3.12100.0% of flowOrdinary SharesSEC:0001104659-21-069879:0
4 of 4 declarations
About Einhorn Andrew J.
Andrew J. Einhorn is the Chief Financial Officer at Osmotica Pharmaceuticals plc and RVL Pharmaceuticals plc. He oversees the financial management of the companies, ensuring compliance and efficiency in financial operations.
